Monthly View Flat View Weekly View Daily View Categories

Event: 'Non-Statin Therapy for LDL Cholesterol Reduction in Primary and SecondaryPrevention'


CME Satellite Symposium

Date: Friday, February 23, 2018 (06:45 PM-09:00 PM)
Duration: 3 Hour(s)
  Location: Hyatt Hill Country, Fredericksburg Ballroom A-D, 9800 Hyatt Resort Drive, San Antonio, Texas

In this program, our faculty James Underberg, MD, MS (Chair); Alan Brown, MD; Peter Jones, MD, and Pamela Morris, MD will focus on the evidence with, and use of, non-statin therapies for LDL-C lowering in the settings of primary and secondary prevention. An interpretation of recently presented and published secondary analyses from cardiovascular outcome trials with non-statin agents will provide lipid specialists with a more comprehensive evaluation of the efficacy and safety of non-statin therapy in patients with atherosclerotic cardiovascular disease (ASCVD). Attendees will also receive an expert assessment of non-statin therapy for primary prevention.  Four interactive challenging cases for lipid specialists with “real-world” patients will enable faculty members to describe best management strategies.